COMPASS Pathways plc
NASDAQ: CMPS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Kabir Kumar Nath
- Employees
- 166
- Headquarters
- London, United Kingdom
- IPO year
- 2020
- Market cap
- $1.2B
- Website
- https://compasspathways.com
Loading CMPS…
Loading profile data…Frequently asked questions about CMPS
What does COMPASS Pathways plc (CMPS) do?
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical tria...
Where does CMPS trade?
COMPASS Pathways plc (CMPS) trades on the NASDAQ Global Select.
What sector is CMPS in?
COMPASS Pathways plc (CMPS) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of COMPASS Pathways plc?
Kabir Kumar Nath is the chief executive officer of COMPASS Pathways plc (CMPS).
Where is COMPASS Pathways plc headquartered?
COMPASS Pathways plc is headquartered in United Kingdom.
Does CMPS pay a dividend?
COMPASS Pathways plc (CMPS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CMPS go public?
COMPASS Pathways plc (CMPS) completed its initial public offering in 2020.
Is CMPS an ADR?
Yes — CMPS is an American Depositary Receipt; its underlying shares trade on a non-US exchange. COMPASS Pathways plc reporting and dividends follow the underlying issuer.